Jennifer Gunter & Eric Topol - Discuss Womenâs Health and Recent Changes by FDA for MHT
The demonization of hormone replacement therapy for perimenopausal women and the undercreation of its health benefits ranks among the greatest mistakes of modern medicine.
Jennifer Gunter & Eric Topol - Discuss Womenâs Health and Recent Changes by FDA for MHT
With the exception of antibiotics and vaccines, there may be no medication in the modern world that can improve the health outcomes of older women on a population level more than hormone therapy.
Jennifer Gunter & Eric Topol - Discuss Womenâs Health and Recent Changes by FDA for MHT
No, it's very clear from both the JAMA and the Wall Street Journal article, as you said, these were picking specific interpretations of, you know, ice pick views of certain data like the cognitive benefit and whatnot.
Jennifer Gunter & Eric Topol - Discuss Womenâs Health and Recent Changes by FDA for MHT
So you just wonder in this population back from 20 years ago, they reported on plus 22, 23 years ago, that they were picking out on a study that this was preventive treatment rather than symptomatic treatment and the wrong women.
Jennifer Gunter & Eric Topol - Discuss Womenâs Health and Recent Changes by FDA for MHT
with the modern preparations in women who are within 10 years and 60 years old from menopause, you know, we don't have a real prospective randomized child, right?